Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)

Stable Identifier
R-HSA-5578998
Type
Pathway
Species
Homo sapiens
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

The gamma-glutamyl cycle is a six-enzyme cycle that represents the primary pathway for glutathione synthesis and degradation. One step is the cleavage of 5-oxo-L-proline (OPRO) to form L-glutamate, coupled to the hydrolysis of ATP. This is catalysed by 5-oxoprolinase (OPLAH) is a homodimeric, cytosolic protein. Defects in OPLAH can cause 5-oxoprolinase deficiency (OPLAHD; MIM:260005), an extremely rare disorder of the gamma-glutamyl cycle about which debate continues as to whether it is a disorder or just a biochemical condition with no adverse clinical effects apart from 5-oxoprolinuria (Calpena et al. 2013, Almaghlouth et al. 2012, Aoyama & Nakaki 2013).

Literature References
PubMed ID Title Journal Year
21651516 5-Oxoprolinase deficiency: report of the first human OPLAH mutation

Almaghlouth, IA, Mohamed, JY, Al-Amoudi, M, Al-Ahaidib, L, Al-Odaib, A, Alkuraya, FS

Clin. Genet. 2012
23430506 5-Oxoprolinuria in Heterozygous Patients for 5-Oxoprolinase (OPLAH) Missense Changes

Calpena, E, Casado, M, Martínez-Rubio, D, Nascimento, A, Colomer, J, Gargallo, E, Garcia-Cazorla, A, Palau, F, Artuch, R, Espinós, C

JIMD Rep 2013
24145751 Impaired glutathione synthesis in neurodegeneration

Aoyama, K, Nakaki, T

Int J Mol Sci 2013
Participants
Participant Of
Disease
Name Identifier Synonyms
inherited metabolic disorder 655 Metabolic hereditary disorder, Inborn Errors of Metabolism, inborn metabolism disorder
Authored
Reviewed
Created
Cite Us!